Dr. Chris Pak

Dr. Chris Pak, Co-Founder and Chief Executive Officer of Molecular Targeting Technologies, Inc., has been in the Biotechnology field for over two decades. He was formerly associated with Centocor, a top-tier biopharmaceutical company, now a subsidiary of Johnson and Johnson. Dr. Pak has served as the President of the Chinese American Society of Nuclear Medicine, the Vice Chair of the Global Monte Jade Science and Technology Association, and the Chairman of the Chinese Entrepreneur Association which he co-founded. Currently, he is a board member of Monte Jade Science and Technology Association of Mid-Atlantic. Dr. Pak holds numerous patents and has published more than sixty articles covering the use of antibodies and small molecules for cancer and cardiovascular diseases. Dr. Pak’s recent awards include the 2014 Lifetime Achievement Award from the Chinese American Society of Nuclear Medicine and Molecular Imaging, State University of New York at Plattsburgh Distinguished Visiting Alumnus Award, SUNY Honor Roll of Alumni, Ben Franklin Emerging Business Award and Outstanding Asian American Business Award.